We are live on ! Find out more

2,990 hedge funds and large institutions have $163B invested in Merck in 2022 Q3 according to their latest regulatory filings, with 121 funds opening new positions, 1,374 increasing their positions, 1,114 reducing their positions, and 104 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more call options, than puts

Call options by funds: $2.42B | Put options by funds: $1.79B

23% more repeat investments, than reductions

Existing positions increased: 1,374 | Existing positions reduced: 1,114

16% more first-time investments, than exits

New positions opened: 121 | Existing positions closed: 104

0.78% more ownership

Funds ownership: 74.29%75.08% (+0.78%)

1% less funds holding

Funds holding: 3,0142,990 (-24)

4% less capital invested

Capital invested by funds: $171B → $163B (-$7.45B)

6% less funds holding in top 10

Funds holding in top 10: 238224 (-14)

Holders
2,990
Holders Change
-24
Holders Change %
-0.8%
% of All Funds
51.5%
Holding in Top 10
224
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-5.88%
% of All Funds
3.86%
New
121
Increased
1,374
Reduced
1,114
Closed
104
Calls
$2.42B
Puts
$1.79B
Net Calls
+$627M
Net Calls Change
+$85.4M
Name Holding Trade Value Shares
Change
Change in
Stake
RIM
926
Redpoint Investment Management
Australia
$4.78M -$628K -7,039 -11%
MWM
927
Marietta Wealth Management
Georgia
$4.78M +$181K +2,028 +4%
CG
928
Cutler Group
California
$4.77M +$4.95M +55,434 New
Westfield Capital Management
929
Westfield Capital Management
Massachusetts
$4.77M -$103K -1,159 -2%
BFO
930
Boston Family Office
Massachusetts
$4.75M -$364K -4,073 -7%
BIM
931
Bridges Investment Management
Nebraska
$4.72M -$71.4K -800 -1%
GIA
932
Gladstone Institutional Advisory
Florida
$4.7M +$258K +2,885 +6%
BAMCO Inc
933
BAMCO Inc
New York
$4.69M +$643K +7,200 +15%
MIA
934
MainStreet Investment Advisors
Illinois
$4.66M
JHCP
935
Jackson Hole Capital Partners
Oklahoma
$4.64M +$66.5K +745 +1%
HCM
936
Howland Capital Management
Massachusetts
$4.64M +$170K +1,906 +4%
CCT
937
Chemung Canal Trust
New York
$4.64M +$8.57K +96 +0.2%
CA
938
Cullinan Associates
Kentucky
$4.63M +$650K +7,276 +16%
IIM
939
Ipswich Investment Management
Massachusetts
$4.63M -$119K -1,328 -2%
RWM
940
Ritholtz Wealth Management
New York
$4.62M +$2.4M +26,883 +101%
BS
941
Boenning & Scattergood
Pennsylvania
$4.62M +$458K +5,134 +11%
BCM
942
Birmingham Capital Management
Alabama
$4.61M -$435K -4,875 -8%
CIC
943
Cornercap Investment Counsel
Georgia
$4.59M -$48.7K -546 -1%
JAFL
944
Jay A. Fishman Ltd
Michigan
$4.59M -$4.46K -50 -0.1%
RC
945
Roundview Capital
New Jersey
$4.58M +$38.5K +431 +0.8%
MGP
946
Metis Global Partners
California
$4.57M +$294K +3,291 +7%
PTC
947
Philadelphia Trust Company
Pennsylvania
$4.56M +$404K +4,528 +9%
HSA
948
HBK Sorce Advisory
Pennsylvania
$4.56M +$601K +6,730 +15%
AAS
949
Ameritas Advisory Services
Nebraska
$4.51M +$255K +2,862 +6%
PCS
950
Personal CFO Solutions
New Jersey
$4.51M -$233K -2,612 -5%

MRK Hedge Fund Activity: Q3 2022 in Review

2,990 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2022, worth a combined $163B — down 4.4% from $171B a quarter earlier.

Buyers outnumbered sellers: 121 funds opened new MRK positions and 104 closed out — a net gain of 17 holders — while 1,374 added to existing stakes and 1,114 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $1.47B. The largest seller was Marshall Wace, cutting an estimated $459M.

  • 2,990 institutional investors held Merck (MRK) as of Q3 2022, down from 3,014 in Q2 2022.
  • Funds reported $163B of Merck stock for Q3 2022, down 4.4% quarter-over-quarter.
  • 121 funds opened new Merck positions in Q3 2022 and 104 closed out, a net change of +17 holders.
  • The largest Merck buyer in Q3 2022 was Janus Henderson Group, an estimated $1.47B added.
  • The largest Merck seller in Q3 2022 was Marshall Wace, an estimated $459M sold.

Based on aggregated 13F filings for Q3 2022.